Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 11:58:41 - browse：2165

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Readout LOUD podcast: ASCO preview, a Duchenne trial failure

WSS

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Cord blood banking comes at a high cost to babies

Chimpanzees, like humans and whales, get menopause: Study

hotspot

Wikipedia

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Why Sanofi got shellacked over its spinoff

Medical leaders decry Supreme Court decision on affirmative action

The Pandemic Treaty must support building strong health systems

The cancer drug shortage isn’t new — and neither are the solutions

BMI, flaws aside, is found to be useful estimate of body fat in youth

As demand for Covid shots wanes, Moderna seeks its next success

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

In Memoriam: Notable people who died in 2023

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

Diversifying clinical trials isn't enough to close racial gaps: study

The FDA weighs the risks of candy

Biden's order seeks to regulate AI risk without stifling innovation

The Pandemic Treaty must support building strong health systems

Paying for Covid pills will soon shift to insurers

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

leisure time

hotspot

knowledge

Wikipedia